Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)
NCT00367315
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1684
Enrollment
INDUSTRY
Sponsor class
Conditions
Knee Osteoarthritis
Interventions
DRUG:
Lumiracoxib
Sponsor
Novartis